Company: PLSAY
Filing Date: 2025-09-03
Form Type: 6-K
Source: 0001884082-25-000020
Chunk: 0

Company: Polestar Automotive Holding UK PLC
Filing Date: 2025-09-03
Form: 6-K
Chunk 0
---
#### The Polestar Group
<div align='center'>Unaudited Condensed Consolidated Interim Financial Statements as of June 30, 2025 and for</div>

#### the Six months ended June 30, 2025 and 2024
<div align='center'>F-1</div>

#### Polestar Automotive Holding UK PLC
<div align='center'>INDEX TO THE UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS FOR THE SIX MONTHS ENDED JUNE 30, 2025 AND 2024</div>

| Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss for the Six months ended June 30, 2025 and 2024 
 Unaudited Condensed Consolidated Statement of Financial Position as of June 30, 2025 and December 31, 2024                |     | F-3 
 F-4 |
|:--------------------------------------------------------------------------------------------------------------------------|:----|:----|
| Unaudited Condensed Consolidated Statement of Changes in Equity for the Six months ended June 30, 2025 and 2024           |     | F-6 |
| Unaudited Condensed Consolidated Statement of Cash Flows for the Six months ended June 30, 2025 and 2024                  |     | F-7 |
| Notes to the Unaudited Condensed Consolidated Interim Financial Statements                                                |     | F-8 |

<div align='center'>F-2

Polestar Automotive Holding UK PLC

Unaudited Condensed Consolidated Statement of Loss and Comprehensive Loss

(in thousands of U.S. dollars except per share data)</div>

|                                                                                    |     |      |     | For the six months ended June 30, |            |     |      |          |
|                                                                                    |     | Note |     |                              2025 |            |     | 2024 |          |
| Revenue                                                                            |     |    3 |     |                                   |  1,422,605 |     |      |  909,247 |
| Cost of sales                                                                      |     |    4 |     |                                   | -2,125,729 |     |      | -932,533 |
| Impairment expense, net of reversals                                               |     |    4 |     |                                   |   -723,524 |     |      |        — |
| Other cost of sales                                                                |     |    4 |     |                                   | -